More than 4 out of 10 dementia patients with Alzheimer's disease stop taking therapeutic drugs within a year of starting ...

MIRA advances Ketamir-2 in the clinic for neuropathic pain while broadening development into neuropsychiatric disorders such as PTSD MIAMI, FLORIDA / ACCESS Newswire / September 16, 2025 / MIRA ...

Jupiter Hospital recently managed a rare and challenging case of NMDA receptor positive autoimmune encephalitis in a ...

A systematic review and meta-analysis of over 140 studies sheds light on which drug classes, including NMDA-receptor antagonists and VGSC blockers, can reduce secondary hyperalgesia.

Autism spectrum disorder (ASD) is widely known for its core features, which include difficulties in social communication and ...

Neurocrine Biosciences, Inc. ( NASDAQ: NBIX) TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit September 17, 2025 12:40 PM EDT ...